Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 134

1.

TGF-alpha antisense gene therapy inhibits head and neck squamous cell carcinoma growth in vivo.

Endo S, Zeng Q, Burke NA, He Y, Melhem MF, Watkins SF, Lango MN, Drenning SD, Huang L, Rubin Grandis J.

Gene Ther. 2000 Nov;7(22):1906-14.

PMID:
11127578
[PubMed - indexed for MEDLINE]
Free Article
2.

Inhibition of human squamous cell carcinoma growth in vivo by epidermal growth factor receptor antisense RNA transcribed from the U6 promoter.

He Y, Zeng Q, Drenning SD, Melhem MF, Tweardy DJ, Huang L, Grandis JR.

J Natl Cancer Inst. 1998 Jul 15;90(14):1080-7. Erratum in: J Natl Cancer Inst 2002 Apr 17;94(8):633.

PMID:
9672256
[PubMed - indexed for MEDLINE]
Free Article
3.

Downmodulation of TGF-alpha protein expression with antisense oligonucleotides inhibits proliferation of head and neck squamous carcinoma but not normal mucosal epithelial cells.

Grandis JR, Chakraborty A, Zeng Q, Melhem MF, Tweardy DJ.

J Cell Biochem. 1998 Apr 1;69(1):55-62.

PMID:
9513046
[PubMed - indexed for MEDLINE]
4.

Inhibition of epidermal growth factor receptor gene expression and function decreases proliferation of head and neck squamous carcinoma but not normal mucosal epithelial cells.

Rubin Grandis J, Chakraborty A, Melhem MF, Zeng Q, Tweardy DJ.

Oncogene. 1997 Jul 24;15(4):409-16.

PMID:
9242377
[PubMed - indexed for MEDLINE]
Free Article
5.

Abrogation of head and neck squamous cell carcinoma growth by epidermal growth factor receptor ligand fused to pseudomonas exotoxin transforming growth factor alpha-PE38.

Thomas SM, Zeng Q, Epperly MW, Gooding WE, Pastan I, Wang QC, Greenberger J, Grandis JR.

Clin Cancer Res. 2004 Oct 15;10(20):7079-87.

PMID:
15501988
[PubMed - indexed for MEDLINE]
Free Article
6.

Abrogation of VEGF expression in human head and neck squamous cell carcinoma decreases angiogenic activity in vitro and in vivo.

Riedel F, Götte K, Li M, Hörmann K, Grandis JR.

Int J Oncol. 2003 Sep;23(3):577-83.

PMID:
12888890
[PubMed - indexed for MEDLINE]
7.

In vitro and in vivo characteristics of human squamous cell carcinoma of the head and neck cells engineered to secrete interleukin-2.

Nagashima S, Reichert TE, Kashii Y, Suminami Y, Chikamatsu K, Whiteside TL.

Cancer Gene Ther. 1997 Nov-Dec;4(6):366-76.

PMID:
9408607
[PubMed - indexed for MEDLINE]
8.

The role of adenovirus-mediated retinoblastoma 94 in the treatment of head and neck cancer.

Li D, Day KV, Yu S, Shi G, Liu S, Guo M, Xu Y, Sreedharan S, O'Malley BW Jr.

Cancer Res. 2002 Aug 15;62(16):4637-44.

PMID:
12183420
[PubMed - indexed for MEDLINE]
Free Article
9.

Inhibition of tumor growth in liver epithelial cells transfected with a transforming growth factor alpha antisense gene.

Laird AD, Brown PI, Fausto N.

Cancer Res. 1994 Aug 1;54(15):4224-32.

PMID:
8033155
[PubMed - indexed for MEDLINE]
Free Article
10.

Abrogation of transforming growth factor-alpha/epidermal growth factor receptor autocrine signaling by an RXR-selective retinoid (LGD1069, Targretin) in head and neck cancer cell lines.

Song JI, Lango MN, Hwang JD, Drenning SD, Zeng Q, Lamph WW, Grandis JR.

Cancer Res. 2001 Aug 1;61(15):5919-25.

PMID:
11479234
[PubMed - indexed for MEDLINE]
Free Article
11.

Head and neck squamous cell carcinoma targeted chemosensitization.

Figures MR, Wobb J, Araki K, Liu T, Xu L, Zhu H, O'Malley BW Jr, Li D.

Otolaryngol Head Neck Surg. 2009 Aug;141(2):177-83. doi: 10.1016/j.otohns.2009.04.024.

PMID:
19643248
[PubMed - indexed for MEDLINE]
12.

Adenovirus-mediated expression of dominant negative c-myb induces apoptosis in head and neck cancer cells and inhibits tumor growth in animal model.

Kim SY, Yang YS, Hong KH, Jang KY, Chung MJ, Lee DY, Lee JC, Yi HK, Nam SY, Hwang PH.

Oral Oncol. 2008 Apr;44(4):383-92. Epub 2007 Aug 8.

PMID:
17690006
[PubMed - indexed for MEDLINE]
13.

EGFR antisense treatment of human HNSCC cell lines down-regulates VEGF expression and endothelial cell migration.

Riedel F, Götte K, Li M, Hörmann K, Grandis JR.

Int J Oncol. 2002 Jul;21(1):11-6.

PMID:
12063543
[PubMed - indexed for MEDLINE]
14.

Treatment of the T98G glioblastoma cell line with antisense oligonucleotides directed toward mRNA encoding transforming growth factor-alpha and the epidermal growth factor receptor.

Rubenstein M, Glick R, Lichtor T, Mirochnik Y, Chou P, Guinan P.

Med Oncol. 2001;18(2):121-30.

PMID:
11778757
[PubMed - indexed for MEDLINE]
15.

Antibody-mediated blockade of integrin alpha v beta 6 inhibits tumor progression in vivo by a transforming growth factor-beta-regulated mechanism.

Van Aarsen LA, Leone DR, Ho S, Dolinski BM, McCoon PE, LePage DJ, Kelly R, Heaney G, Rayhorn P, Reid C, Simon KJ, Horan GS, Tao N, Gardner HA, Skelly MM, Gown AM, Thomas GJ, Weinreb PH, Fawell SE, Violette SM.

Cancer Res. 2008 Jan 15;68(2):561-70. doi: 10.1158/0008-5472.CAN-07-2307.

PMID:
18199553
[PubMed - indexed for MEDLINE]
Free Article
16.

Eradication of p53-mutated head and neck squamous cell carcinoma xenografts using nonviral p53 gene therapy and photochemical internalization.

Ndoye A, Dolivet G, Høgset A, Leroux A, Fifre A, Erbacher P, Berg K, Behr JP, Guillemin F, Merlin JL.

Mol Ther. 2006 Jun;13(6):1156-62. Epub 2006 Mar 27.

PMID:
16564229
[PubMed - indexed for MEDLINE]
17.

Antiangiogenic therapy of head and neck squamous cell carcinoma by vascular endothelial growth factor antisense therapy.

Riedel F, Götte K, Hörmann K, Grandis JR.

Adv Otorhinolaryngol. 2005;62:103-20.

PMID:
15608422
[PubMed - indexed for MEDLINE]
18.

Antitumor mechanisms of systemically administered epidermal growth factor receptor antisense oligonucleotides in combination with docetaxel in squamous cell carcinoma of the head and neck.

Thomas SM, Ogagan MJ, Freilino ML, Strychor S, Walsh DR, Gooding WE, Grandis JR, Zamboni WC.

Mol Pharmacol. 2008 Mar;73(3):627-38. Epub 2007 Nov 19.

PMID:
18025070
[PubMed - indexed for MEDLINE]
Free Article
19.

EphB4 provides survival advantage to squamous cell carcinoma of the head and neck.

Masood R, Kumar SR, Sinha UK, Crowe DL, Krasnoperov V, Reddy RK, Zozulya S, Singh J, Xia G, Broek D, Schönthal AH, Gill PS.

Int J Cancer. 2006 Sep 15;119(6):1236-48.

PMID:
16615113
[PubMed - indexed for MEDLINE]
20.

Inhibition of the EGFR with nanoparticles encapsulating antisense oligonucleotides of the EGFR enhances radiosensitivity in SCCVII cells.

Ping Y, Jian Z, Yi Z, Huoyu Z, Feng L, Yuqiong Y, Shixi L.

Med Oncol. 2010 Sep;27(3):715-21. doi: 10.1007/s12032-009-9274-0. Epub 2009 Aug 4.

PMID:
19653138
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk